Verrica Pharmaceuticals Inc (NASDAQ:VRCA)

4.57
Delayed Data
As of Jan 30
 -0.14 / -2.97%
Today’s Change
1.77
Today|||52-Week Range
9.22
+66.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Operating ActivitiesNet Income / Starting Line-6.7M-6.1M-7.5M-7.0M
 
 
 
 
 
Depreciation5.0K10.0K40.0K41.0K
 
 
 
 
 
Total Other Cash Flow1.5M-1.2M421.0K563.0K
 
 
 
 
 
Funds From Operations-5.3M-7.3M-7.0M-6.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-128.0K-399.0K-101.0K-1.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-5.1M-6.9M-6.9M-5.0M
 
 
 
 
 
 
InvestingIncrease In Investments-58.6M-20.5M-21.3M-27.9M
 
 
 
 
 
Decrease In Investments0.00--42.4M28.2M
 
 
 
Capital Expenditures-13.0K-151.0K0.000.00
 
 
 
Other Investing - Uses0.00-499.0K0.000.00
 
 
Net Cash Flow Investing-58.6M-21.1M21.1M263.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00-58.0K
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale-1.1M9.0K3.0K212.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-1.1M9.0K3.0K154.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-64.8M-28.0M14.2M-4.6M